CEBP Candidate Pathways, Whole Genome Scans: Reconciling Results, Looking into the Future
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

Clinical Intervention

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 1-10 of 60 total displayed.

Most recent content

Cancer Prevention Research
Research Article
Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
Frank L. Meyskens, Jr., Christine E. McLaren, Daniel Pelot, Sharon Fujikawa-Brooks, Philip M. Carpenter, Ernest Hawk, Gary Kelloff, Michael J. Lawson, Jayashri Kidao, John McCracken, C. Gregory Albers, Dennis J. Ahnen, D. Kim Turgeon, Steven Goldschmid, Peter Lance, Curt H. Hagedorn, Daniel L. Gillen, and Eugene W. Gerner
Cancer Prevention Research first published on Apr 14, 2008 as doi: 1940-6207.CAPR-08-0042. [Abstract] Online First [PDF]  

Cancer Prevention Research
Research Article
Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial
Nancy L. Cho, Mark Redston, Ann G. Zauber, Adelaide M. Carothers, Jason Hornick, Andrew Wilton, Stephen Sontag, Norman Nishioka, Francis M. Giardiello, John R. Saltzman, Chris Gostout, Craig J. Eagle, Ernest T. Hawk, and Monica M. Bertagnolli
Cancer Prevention Research first published on Apr 14, 2008 as doi: 1940-6207.CAPR-07-0011. [Abstract] Online First [PDF]  

Past content

Mol. Cancer Ther.
Research Articles: Therapeutics, Targets, and Development
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes
Ronald A. Lubet, Eva Szabo, Konstantin Christov, Ann M. Bode, Marna E. Ericson, Vernon E. Steele, M. Margaret Juliana, and Clinton J. Grubbs
Mol. Cancer Ther. 2008; 7: 972-979. [Abstract] [Full text] [PDF]  

Cancer Epidemiol. Biomarkers Prev.
Null Results in Brief
The Ratio of Specific Polychlorinated Biphenyls as a Surrogate Biomarker of Cytochrome P4501A2 Activity—A Pharmaco-Metabonomic Study in Humans
Xibiao Ye, Edward F. Fitzgerald, Marta I. Gomez, George H. Lambert, and Matthew P. Longnecker
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 1013-1015. [Full text] [PDF]  

Clin. Cancer Res.
Cancer Therapy: Clinical
Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions
Vassiliki A. Papadimitrakopoulou, William N. William, Jr., Andrew J. Dannenberg, Scott M. Lippman, J. Jack Lee, Frank G. Ondrey, Douglas E. Peterson, Lei Feng, Anthea Atwell, Adel K. El-Naggar, Cherie-Ann Nathan, Joseph I. Helman, Baoheng Du, Bevan Yueh, and Jay O. Boyle
Clin. Cancer Res. 2008; 14: 2095-2101. [Abstract] [Full text] [PDF]  

Cancer Prevention Research
Research Article
Intratumoral Epiregulin Is a Marker of Advanced Disease in Non–Small Cell Lung Cancer Patients and Confers Invasive Properties on EGFR-Mutant Cells
Jie Zhang, Kentaro Iwanaga, Kuicheon C. Choi, Marie Wislez, Maria Gabriela Raso, Wei Wei, Ignacio I. Wistuba, and Jonathan M. Kurie
Cancer Prevention Research first published on Mar 31, 2008 as doi: 1940-6207.CAPR-08-0014. [Abstract] Online First [PDF]  

Cancer Epidemiol. Biomarkers Prev.
Research Articles
Urinary 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine in Patients with Parasite Infection and Effect of Antiparasitic Drug in Relation to Cholangiocarcinogenesis
Raynoo Thanan, Mariko Murata, Somchai Pinlaor, Paiboon Sithithaworn, Narong Khuntikeo, Walaluk Tangkanakul, Yusuke Hiraku, Shinji Oikawa, Puangrat Yongvanit, and Shosuke Kawanishi
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 518-524. [Abstract] [Full text] [PDF]  

Cancer Epidemiol. Biomarkers Prev.
Research Articles
Decreased Expression of UK114 Is Related to the Differentiation Status of Human Hepatocellular Carcinoma
Chin-Liew Chong, Shiu-Feng Huang, Cheng-po Hu, Ya-Ling Chen, Hsin-Ying Chou, Gar-Yang Chau, Jin-Yuh Shew, Yue-Lin Tsai, Chiung-Tong Chen, Chungming Chang, and Mong-Liang Chen
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 535-542. [Abstract] [Full text] [PDF]  

Cancer Epidemiol. Biomarkers Prev.
Research Articles
Progestin Treatment Induces Apoptosis and Modulates Transforming Growth Factor-β in the Uterine Endometrium
Gustavo C. Rodriguez, B.J. Rimel, William Watkin, Jane M. Turbov, Cathy Barry, Hongyan Du, George L. Maxwell, and J.M. Cline
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 578-584. [Abstract] [Full text] [PDF]  

Cancer Epidemiol. Biomarkers Prev.
Research Articles
Comparative Bioavailability of Sulindac in Capsule and Tablet Formulations
Joel M. Reid, Sumithra J. Mandrekar, Elsa C. Carlson, W. Scott Harmsen, Erin M. Green, Renee M. McGovern, Eva Szabo, Matthew M. Ames, Daniel Boring, Paul J. Limburg for the Cancer Prevention Network
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 674-679. [Abstract] [Full text] [PDF]  

[Next page]
Pages: 1 2 3 4 5 6

* Collected Resources Home


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2008 by the American Association for Cancer Research.